Newsroom

Press Releases

Ed Amat, Chief Growth Officer

Press Release

BioAgilytix Welcomes Ed Amat as New Chief Growth Officer

Durham, NC – May 30, 2024 – BioAgilytix, a leading global bioanalytical laboratory , is pleased to announce the appointment of Ed Amat as Chief…

Press Release

BBI and BioAgilytix partner to streamline and simplify bioanalytical testing

BBI Solutions OEM Limited (BBI), a trusted expert provider of end-to-end solutions for the development of high-performance assays, has signed a partnership agreement with BioAgilytix,…

Press Release

Davide Molho, DVM, Life Sciences Industry Veteran joins BioAgilytix as CEO

BioAgilytix Labs, LLC (BioAgilytix), a leading global bioanalytical laboratory, today announced the appointment of Davide Molho, DVM, as its new Chief Executive Officer (CEO) with…

Press Release

A3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USA

A3P Biomedical AB, a Swedish company specialized in advanced prostate cancer diagnostics, and BioAgilytix, a global bioanalytical services provider, have entered a partnership with the…

Media Coverage

Media Coverage

Boosting Hamburg as a Science and Pharmaceutical Location Together With BioAgilytix

Andreas Rieckhof, State Councilor for Economic Affairs, LSN Managing Director Dr. Jürgen Walkenhorst and Juliane Worm, LSN Director Innovation & Technologies, visited the European headquarters…

Media Coverage

Pre-existing Immunogenicity: How Will Cell and Gene Therapies Change Our Testing Approach?

In this article, Chief Scientific Officer at BioAgilytix, Jim McNally, Ph.D., explores why bioanalysts should prepare for the impending wave of C&GTs entering the development…

Media Coverage

Bioanalytical Needs And Biosimilars: How Does The Molecule Compare?

Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions of this product to enter…